Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Epitomics
Burlingame, California, United Statesabcam.com ↗
- Ownership
- Private
- Employees
- ~250
- Development stage
- Commercial
01
Overview
Epitomics developed and commercialized proprietary rabbit monoclonal antibody technology ("RabMAb®") with superior binding affinity and bioactivity. The company supplied high-quality antibodies for research and diagnostic use globally. It did not have a therapeutic pipeline but spun off Apexigen to pursue therapeutic development using its platform.
Clinical results are not applicable as the company focused on reagent/diagnostic products rather than drugs.
The company was acquired by Abcam in March/April 2012 for $155–$170 million.
After the acquisition, its products became available through Abcam’s global distribution network.
- Therapeutic areas
- OncologyOther
- Modalities
- Monoclonal antibodyAntibody (specifically Rabbit Monoclonal Antibody)Biologic
- Industry
- Protein Biomarker Diagnostics
02
Partnerships
National Cancer Institute’s Center for Cancer Research—for development of novel cancer-related antibodies
Beyond the preview
Go deeper on Epitomics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Epitomics.